EPLAW PATENT BLOG

UK – CANTEL V. ARC

Posted: March 9th, 2018

Cantel Medical (UK) Ltd and Cantel (UK) Limited v Arc Medical Design Limited [2018] EWHC 345 (Pat), UK Patents Court, Hacon J In order to clear the path to market for its AmplifEYE endoscopic device, Cantel sought revocation and declarations of non-infringement of Arc’s UK national and European patents relating to Arc’s Endocuff and Endocuff […]

READ MORE

SE – Sandoz v. ViiV Healthcare

Posted: March 2nd, 2018

Sandoz A/S v. ViiV Healthcare UK Limited, Patent and Market Court of Appeal, Sweden, 30 June 2017, Docket No. PMÖ 3565-17 Sandoz requested that the preliminary injunction barring its pharmaceutical products Abacavir/Limavudine Sandoz 600 mg/300 mg from being marketed and sold on the Swedish market be vacated. The Patent and Market Court of Appeal overturned […]

READ MORE

NL – Ono v. Pfizer

Posted: March 1st, 2018

Ono Pharmaceutical Co. Limited v. Pfizer Inc., Interlocutory Judge District Court The Hague, 27 February 2018, Case no. ECLI:NL:RBDHA:2018:2284 Ono filed a European patent application EP ‘517 A1 entitled: ‘Immunopotentiating compositions comprising anti-PD-L1 antibodies’. After the rejection of Pfizer’s third party observations at the EPO, Pfizer lodged proceedings at the German Verwaltungsgericht in Munich claiming […]

READ MORE

NL – Celltrion v. Biogen / English translation

Posted: February 28th, 2018

Celltrion Inc. v. Biogen Inc., District Court The Hague, 21 February 2018, now including an English translation, with thanks to Daan van der Lange, Jan Pot and Boukje van der Maazen, Brinkhof Biogen holds EP 2055313  that relates to a ‘Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody’. Celltrion instigated invalidity […]

READ MORE

NL – LEO Pharma v. Sandoz

Posted: February 21st, 2018

LEO Pharma A/S v. Sandoz, Court of Appeal of The Hague, the Netherlands, 7 November 2017, published 12 February 2018, Case no. ECLI:NL:GHDHA:2017:4029 LEO Pharma is the holder of the European patent EP 2 455 083 B1 titled “Pharmaceutical composition for dermal use comprising calcipotriol and betamethasone for treating psoriasis”. The patent was granted on […]

READ MORE

UK – L’Oréal v. RN Ventures

Posted: February 16th, 2018

L’Oréal SA and L’Oréal (UK) Ltd v RN Ventures Ltd, UK Patents Court, 5 February 2018, Carr J This case concerned the alleged infringement of L’Oréal’s EP (UK) 1 722 699 B1 and two registered community designs. The defendant sold a range of “Magnitone” electronic facial skin care devices. The case was heard under the […]

READ MORE

ES – Gilead v. Teva & Mylan / Tenofovir + Emtricitabine / Interim injunction opposition

Posted: February 7th, 2018

Gilead Biopharmaceutics Ireland UC., Gilead Sciences, S.L.U., Gilead Sciences Ireland UC., Gilead Sciences, Inc. v. Teva Pharma, S.L.U, Mylan Pharmaceuticals, S.L., Mylan S.A.S., Barcelona Commercial Court No. 4, 20 October 2017, Docket No. 190/2017 – 197/17 In its decision of 20 October 2017, Barcelona Commercial Court No. 4 reversed its previous rulings pursuant to which […]

READ MORE

ES – ZHENSHI GROUP & JUSHI GROUP v OCV INTELLECTUAL CAPITAL / Selection invention

Posted: February 7th, 2018

Zhenshi Group Hengshi Fiberglass Fabrics Co., LTD & Jushi Group Co., LT v. OCV Intellectual Capital, LLC., Commercial Court of Barcelona N.º 5, Spain, 12 September 2017, Case number: 433/2015 The Commercial Court of Barcelona n.º 5 has handed down its decision in a patent nullity case regarding patent ES 2.1405.941 T9, Spanish part of […]

READ MORE

DE – Federal Supreme Court ‘Drum Unit’

Posted: February 5th, 2018

Judgment of the Federal Supreme Court, Germany, 24 October 2017, docket no. X ZR 55/16, ‘Drum Unit’ With its milestone ‘Drum Unit’decision, the German Federal Supreme Court revisits its case law on the exhaustion of patent rights, and in particular, on the delimitation of ‘permissible use’ on the one hand and the ‘unlawful (re-)making’ of […]

READ MORE

UK – Hospira v. Cubist / Appeal

Posted: February 5th, 2018

Hospira UK Limited v Cubist Pharmaceuticals LLC, Court of Appeal, London, UK, 18 January 2018, [2018] EWCA Civ 12 This is a judgment from an appeal by Cubist Pharmaceuticals LLC (“Cubist”) in which a two-judge panel (Lewison LJ and Kitchin LJ) upheld Henry Carr J’s first instance decision, that Cubist’s patent EP (UK) 2,264,047 (“the […]

READ MORE